Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
December 07, 2020 07:22 ET
|
Repligen Corporation
WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of 1.5 million shares of its common stock....
Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
November 05, 2020 07:30 ET
|
Repligen Corporation
Reports record quarterly revenue of $94.1 million with strong margin expansionOverall revenue grew 35% year-over-year, with organic growth of 31% Raises revenue guidance to $348-$352 million and...
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
October 27, 2020 16:15 ET
|
Repligen Corporation
Proposed ARTeSYN acquisition adds gold standard single-use downstream bioprocessing systemsAdvances Repligen’s Systems strategy in Filtration and Chromatography, complementing TangenX® Flat Sheet...
Repligen to Report Third Quarter 2020 Financial Results
October 22, 2020 07:30 ET
|
Repligen Corporation
- Webcast and Conference Call to Be Held Thursday, November 5, 2020 at 8:30 a.m. EST - WALTHAM, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that...
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
October 01, 2020 06:30 ET
|
Repligen Corporation
WALTHAM, Mass. and HALLE (Saale), Germany, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo...
Repligen Reports Second Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
July 30, 2020 07:30 ET
|
Repligen Corporation
Reports record quarterly revenue of $87.5 millionOverall revenue grew 24% year-over-year, with organic growth of 19% Raises revenue guidance to $332-$340 million for full year 2020, representing...
Repligen to Report Second Quarter 2020 Financial Results
July 15, 2020 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., July 15, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second quarter 2020 financial results on Thursday, July 30,...
Repligen Announces Agreement to Acquire Engineered Molding Technology
June 29, 2020 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into...
Repligen Appoints Carrie Eglinton Manner to Board of Directors
June 15, 2020 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., June 15, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of...
Repligen Reports First Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
May 06, 2020 07:30 ET
|
Repligen Corporation
Reports record quarterly revenue of $76.1 millionOverall revenue grew 25% year-over-year, with organic growth of 16% Strong order load through first four months WALTHAM, Mass., May 06, 2020 ...